临床试验的全球市场调查报告-产业分析，规模，占有率，成长，趋势，2022年～2028年前的预测

Value Market Research深入调查临床试验的全球市场，并预测未来几年行业将出现显着增长。本研究报告提供全球临床试验市场相关之完全产业分析，提供市场规模、市场占有率、增长趋势、2023年至2028年的预测等。该报告以详细的市场介绍和突出报告关键增长数据的执行摘要为首。接续的章节讨论市场价值链、波特五力模型和市场吸引力分析。同时还设立关于COVID-19影响分析的独立章节，以了解市场如何应对疫情。

本报告的市场动态部分详细介绍了当前的市场推动因素/阻碍、课题/风险和未来机遇。本节对企业战略家和新产品开发部门非常有用。临床试验全球市场调查将市场细分化，并根据收益和/或销售额的视点提供市场规模。该数据地区细分，同时国家/地区细分。数据是通过深入的初级访谈和世界各地的行业专家收集而来。详细的调查方法可以在样本报告中找到。这些市场预测受到最新的社会、政治和经济变化以及影响该临床试验市场的当前市场动态所影响。

临床试验市场报告的子章节提供市场竞争力调查，提供一些领先的市场参与者/製造商简介。这些章节涵括可深入了解竞争对手的产品线、财务状况、最新发展以及在行业中拥有最高市场占有率公司所需的丰富资讯。

目录

第1章 序文

• 本报告的内容
  • 目的
  • 主要读者
  • 独特的销售主张(USP)及提供服务
• 调查范围
• 调查手法
  • 市场调查流程
  • 市场调查手法

第2章 摘要整理

• 临床试验市场概况
• 全球临床试验市场概述

第3章 临床试验- 产业分析

• 简介
• 临床试验市场推动市场要素
• 临床试验市场阻碍市场要素
• 临床试验市场机会
• 临床试验市场趋势
• 临床试验市场波特的五力分析
• 临床试验市场魅力度分析
  • 不同阶段市场魅力分析
  • 实验各种设计市场魅力分析
  • 市场魅力分析:各适应症
  • 市场魅力分析:各地区

第4章 价值链分析

• 临床试验的价值链分析
• 临床试验的原料分析
  • 原料的清单
  • 临床试验原料的製造原清单
  • 临床试验的主要原料价格趋势
• 潜在的买主清单
• 行销流通管道
  • 直销
  • 间接行销
  • 行销流通管道开拓趋势

第5章 临床试验的全球市场分析:不同阶段

• 不同阶段概要
• 全球临床试验市场不同阶段分析
• 阶段I的市场分析:各地区
• 阶段II的市场分析:各地区
• 阶段III的市场分析:各地区
• 阶段IV的市场分析:各地区

第6章 全球临床试验市场分析:实验各种设计

• 实验各种设计概要
• 全球临床试验市场分析:实验各种设计
• 介入的市场分析:各地区
• 研究的市场分析:各地区
• 扩大存取(点阅)的市场分析:各地区

第7章 全球临床试验市场分析:各适应症

• 各适应症概要
• 全球临床试验市场分析:各适应症
• 自体免疫/发炎的市场分析:各地区
• 疼痛管理的市场分析:各地区
• 肿瘤的市场分析:各地区
• 中枢神经系统疾病的市场分析:各地区
• 糖尿病的市场分析:各地区
• 肥胖的市场分析:各地区
• 循环系统的市场分析:各地区

第8章 临床试验的全球市场分析:各地区

• 各地区展望
• 简介
• 北美
  • 概要
  • 北美的临床试验市场估计:各国
  • 美国
  • 其他北美地区
• 欧洲
  • 概要
  • 欧洲的临床试验市场预测:市场部门别
  • 欧洲临床试验市场预测:各国
  • 英国
  • 法国
  • 德国
  • 其他的欧洲地区
• 亚太地区
  • 概要
  • 亚太地区的临床试验市场预测:市场部门别
  • 亚太地区的临床试验市场预测:各国
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 南美
  • 概要
  • 南美的临床试验市场预测:市场部门别
  • 南美的临床试验市场预测:各国
  • 巴西
  • 其他的南美地区
• 中东&非洲
  • 概要
  • 中东·非洲的临床试验市场预测:市场部门别
  • 中东·非洲的临床试验市场预测:各国
  • 中东地区
  • 非洲

第9章 临床试验企业的竞争情形

• 临床试验市场竞争
• 伙伴关係/合作/协定
• 合併·收购
• 新产品上市
• 其他的开发

第10章 企业简介

• 企业占有率分析
• 市场集中度
• Charles River Laboratories
  • 企业概要
  • 产品介绍
  • 最近的开发情形
• ICON plc
  • 公司概要
  • 产品介绍
  • 最近的开发情形
• Paraxel International Corporation
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Quintiles IMS
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• SGS SA
  • 公司概要
  • 产品资讯
  • 最近的趋势
• 其他
  • 公司概要
  • 产品资讯
  • 最近的开发情形

第11章 COVID-19疫情造成的影响分析

• COVID-19疫情对市场的影响分析
  • 对生产的直接的影响
  • 供应链与市场的混乱
  • 对企业及金融市场的财务性影响
• COVID-19生产，进口，出口，各需求的影响分析
• COVID-19疫情前后的市场转变
• 冠状病毒(COVID-19)疫情对2020年市场规模的影响预测:情势
• COVID-19:市场相关微观及宏观要素的分析

在公司简介中，财务细节和最近的发展基于可取得的现有信息，可能不包含非上市公司。

Value Market Research deeply researched the Global Clinical Trials Market to foresee a significant growth in the industry over the upcoming years. The global clinical trials market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global clinical trials market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this clinical trials market.

The next sections of the clinical trials market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Phase

Phase I

Phase II

Phase III

Phase IV

By Study Design

Interventional

Observational

Expanded Access

By Indication

Autoimmune/Inflammation

Pain Management

Oncology

CNS Condition

Diabetes

Obesity

Cardiovascular

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Clinical Trials Market
• 2.2. Global Clinical Trials Market Snapshot

3 . CLINICAL TRIALS - INDUSTRY ANALYSIS

• 3.1. Introduction
• 3.2. Market Drivers of Clinical Trials Market
• 3.3. Market Restraints of Clinical Trials Market
• 3.4. Opportunities of Clinical Trials Market
• 3.5. Trends of Clinical Trials Market
• 3.6. Porter's Five Force Analysis of Clinical Trials Market
• 3.7. Clinical Trials Market Attractiveness Analysis
  • 3.7.1 Market Attractive Analysis by Phase
  • 3.7.2 Market Attractive Analysis by Study Design
  • 3.7.3 Market Attractive Analysis by Indication
  • 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Clinical Trials Value Chain Analysis
• 4.2. Clinical Trials Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Clinical Trials Raw Material Manufactures List
  • 4.2.3. Price Trend of Clinical Trials Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY PHASE

• 5.1 Overview by Phase
• 5.2 Global Clinical Trials Market Analysis by Phase
• 5.3 Market Analysis of Phase I by Regions
• 5.4 Market Analysis of Phase II by Regions
• 5.5 Market Analysis of Phase III by Regions
• 5.6 Market Analysis of Phase IV by Regions

6 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY STUDY DESIGN

• 6.1 Overview by Study Design
• 6.2 Global Clinical Trials Market Analysis by Study Design
• 6.3 Market Analysis of Interventional by Regions
• 6.4 Market Analysis of Observational by Regions
• 6.5 Market Analysis of Expanded Access by Regions

7 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY INDICATION

• 7.1 Overview by Indication
• 7.2 Global Clinical Trials Market Analysis by Indication
• 7.3 Market Analysis of Autoimmune/Inflammation by Regions
• 7.4 Market Analysis of Pain Management by Regions
• 7.5 Market Analysis of Oncology by Regions
• 7.6 Market Analysis of CNS Condition by Regions
• 7.7 Market Analysis of Diabetes by Regions
• 7.8 Market Analysis of Obesity by Regions
• 7.9 Market Analysis of Cardiovascular by Regions

8 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America
  • 8.3.1. Overview
  • 8.3.2. North America Clinical Trials Market Estimate by Country
  • 8.3.3. United State
  • 8.3.4. Rest of North America
• 8.4. Europe
  • 8.4.1. Overview
  • 8.4.2. Europe Clinical Trials Market Estimate by Market Segment
  • 8.4.3. Europe Clinical Trials Market Estimate by Country
  • 8.4.4. United Kingdom
  • 8.4.5. France
  • 8.4.6. Germany
  • 8.4.7 Rest of Europe
• 8.5. Asia Pacific
  • 8.5.1. Overview
  • 8.5.2. Asia Pacific Clinical Trials Market Estimate by Market Segment
  • 8.5.3. Asia Pacific Clinical Trials Market Estimate by Country
  • 8.5.4. China
  • 8.5.5. Japan
  • 8.5.6. India
  • 8.5.7. Rest of Asia Pacific
• 8.6. Latin America
  • 8.6.1. Overview
  • 8.6.2. Latin America Clinical Trials Market Estimate by Market Segment
  • 8.6.3. Latin America Clinical Trials Market Estimate by Country
  • 8.6.4. Brazil
  • 8.6.5. Rest of Latin America
• 8.7. Middle East & Africa
  • 8.7.1. Overview
  • 8.7.2. Middle East & Africa Clinical Trials Market Estimate by Market Segment
  • 8.7.3. Middle East & Africa Clinical Trials Market Estimate by Country
  • 8.7.4. Middle East
  • 8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIALS COMPANIES

• 9.1. Clinical Trials Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF CLINICAL TRIALS INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Charles River Laboratories
  • 10.3.1. Company Overview
  • 10.3.2. Financials
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. ICON plc
  • 10.4.1. Company Overview
  • 10.4.2. Financials
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Paraxel International Corporation
  • 10.5.1. Company Overview
  • 10.5.2. Financials
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Quintiles IMS
  • 10.6.1. Company Overview
  • 10.6.2. Financials
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. SGS SA
  • 10.7.1. Company Overview
  • 10.7.2. Financials
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Others
  • 10.8.1. Company Overview
  • 10.8.2. Financials
  • 10.8.3. Products
  • 10.8.4. Recent Developments

11. IMPACT ANALYSIS OF COVID-19 OUTBREAK

• 11.1. Impact Analysis of Covid-19 Outbreak on the Market
  • 11.1.1. Direct Impact on Production
  • 11.1.2. Supply Chain and Market Disruption
  • 11.1.3. Financial Impact on Firms and Financial Markets
• 11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
• 11.3. Pre V/S Post COVID-19 Market
• 11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
• 11.5. COVID-19: Micro and Macro Factor Analysis on the Market

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Global Market Snapshot
• Drivers of the Global Market Impact Analysis
• Restraints of the Global Market Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• COVID-19 Impact Analysis by Production, Import, Export and Demand
• Pre V/S Post COVID-19 Market
• Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
• COVID-19: Micro and Macro Factor Analysis on the Market
• Global Clinical Trials Market Analysis by Phase (USD MN)
• Global Clinical Trials Market Analysis in Phase I by Geography (USD MN)
• Global Clinical Trials Market Analysis in Phase II by Geography (USD MN)
• Global Clinical Trials Market Analysis in Phase III by Geography (USD MN)
• Global Clinical Trials Market Analysis in Phase IV by Geography (USD MN)
• Global Clinical Trials Market Analysis by Study Design (USD MN)
• Global Clinical Trials Market Analysis in Interventional by Geography (USD MN)
• Global Clinical Trials Market Analysis in Observational by Geography (USD MN)
• Global Clinical Trials Market Analysis in Expanded Access by Geography (USD MN)
• Global Clinical Trials Market Analysis by Indication (USD MN)
• Global Clinical Trials Market Analysis in Autoimmune/Inflammation by Geography (USD MN)
• Global Clinical Trials Market Analysis in Pain Management by Geography (USD MN)
• Global Clinical Trials Market Analysis in Oncology by Geography (USD MN)
• Global Clinical Trials Market Analysis in CNS Condition by Geography (USD MN)
• Global Clinical Trials Market Analysis in Diabetes by Geography (USD MN)
• Global Clinical Trials Market Analysis in Obesity by Geography (USD MN)
• Global Clinical Trials Market Analysis in Cardiovascular by Geography (USD MN)
• Global Clinical Trials Market by Geography (USD MN)
• North America Clinical Trials Market Analysis by Phase (USD MN)
• North America Clinical Trials Market Estimate by Study Design (USD MN)
• North America Clinical Trials Market Estimate by Indication (USD MN)
• North America Clinical Trials Market Estimate by Country (USD MN)
• United State Clinical Trials Market Analysis by Phase (USD MN)
• United State Clinical Trials Market Estimate by Study Design (USD MN)
• United State Clinical Trials Market Analysis by Indication (USD MN)
• Rest of North America Clinical Trials Market Analysis by Phase (USD MN)
• Rest of North America Clinical Trials Market Estimate by Study Design (USD MN)
• Rest of North America Clinical Trials Market Estimate by Indication(USD MN)
• Europe Clinical Trials Market Analysis by Phase (USD MN)
• Europe Clinical Trials Market Estimate by Study Design (USD MN)
• Europe Clinical Trials Market Estimate by Indication (USD MN)
• United Kingdom Clinical Trials Market Analysis by Phase (USD MN)
• United Kingdom Clinical Trials Market Estimate by Study Design (USD MN)
• United Kingdom Clinical Trials Market Estimate by Indication (USD MN)
• France Clinical Trials Market Analysis by Phase (USD MN)
• France Clinical Trials Market Estimate by Study Design (USD MN)
• France Clinical Trials Market Estimate by Indication (USD MN)
• Germany Clinical Trials Market Analysis by Phase (USD MN)
• Germany Clinical Trials Market Estimate by Study Design (USD MN)
• Germany Clinical Trials Market Estimate by Indication (USD MN)
• Rest of Europe Clinical Trials Market Analysis by Phase (USD MN)
• Rest of Europe Clinical Trials Market Estimate by Study Design (USD MN)
• Rest of Europe Clinical Trials Market Estimate by Indication (USD MN)
• Asia Pacific Clinical Trials Market Analysis by Phase (USD MN)
• Asia Pacific Clinical Trials Market Estimate by Study Design (USD MN)
• Asia Pacific Clinical Trials Market Estimate by Indication (USD MN)
• Asia Pacific Clinical Trials Market Estimate by Country (USD MN)
• China Clinical Trials Market Analysis by Phase (USD MN)
• China Clinical Trials Market Estimate by Study Design (USD MN)
• China Clinical Trials Market Estimate by Indication (USD MN)
• Japan Clinical Trials Market Analysis by Phase (USD MN)
• Japan Clinical Trials Market Estimate by Study Design (USD MN)
• Japan Clinical Trials Market Estimate by Indication (USD MN)
• India Clinical Trials Market Analysis by Phase (USD MN)
• India Clinical Trials Market Estimate by Study Design (USD MN)
• India Clinical Trials Market Estimate by Indication (USD MN)
• Rest of Asia Pacific Clinical Trials Market Analysis by Phase (USD MN)
• Rest of Asia Pacific Clinical Trials Market Estimate by Study Design (USD MN)
• Rest of Asia Pacific Clinical Trials Market Estimate by Indication (USD MN)
• Latin America Clinical Trials Market Analysis by Phase (USD MN)
• Latin America Clinical Trials Market Estimate by Study Design (USD MN)
• Latin America Clinical Trials Market Estimate by Indication (USD MN)
• Latin America Clinical Trials Market Estimate by Country (USD MN)
• Brazil Clinical Trials Market Analysis by Phase (USD MN)
• Brazil Clinical Trials Market Estimate by Study Design (USD MN)
• Brazil Clinical Trials Market Estimate by Indication (USD MN)
• Rest of Latin America Clinical Trials Market Analysis by Phase (USD MN)
• Rest of Latin America Clinical Trials Market Estimate by Study Design (USD MN)
• Rest of Latin America Clinical Trials Market Estimate by Indication (USD MN)
• Middle East & Africa Clinical Trials Market Analysis by Phase (USD MN)
• Middle East & Africa Clinical Trials Market Estimate by Study Design (USD MN)
• Middle East & Africa Clinical Trials Market Estimate by Indication (USD MN)
• Middle East & Africa Clinical Trials Market Estimate by Country (USD MN)
• Middle East Clinical Trials Market Analysis by Phase (USD MN)
• Middle East Clinical Trials Market Estimate by Study Design (USD MN)
• Middle East Clinical Trials Market Estimate by Indication (USD MN)
• Africa Clinical Trials Market Analysis by Phase (USD MN)
• Africa Clinical Trials Market Estimate by Study Design (USD MN)
• Africa Clinical Trials Market Estimate by Indication (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisiton
• New Product Launch
• Other Developments
• Company Market Share Analysis

LIST OF FIGURES

• Research Scope of Clinical Trials Report
• Market Research Process
• Market Research Methodology
• Global Clinical Trials Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Phase
• Market Attractiveness Analysis by Study Design
• Market Attractiveness Analysis by Indication
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Clinical Trials Market Analysis by Phase (USD MN)
• Global Clinical Trials Market Analysis in Phase I by Geography (USD MN)
• Global Clinical Trials Market Analysis in Phase II by Geography (USD MN)
• Global Clinical Trials Market Analysis in Phase III by Geography (USD MN)
• Global Clinical Trials Market Analysis in Phase IV by Geography (USD MN)
• Global Clinical Trials Market Analysis by Study Design (USD MN)
• Global Clinical Trials Market Analysis in Interventional by Geography (USD MN)
• Global Clinical Trials Market Analysis in Observational by Geography (USD MN)
• Global Clinical Trials Market Analysis in Expanded Access by Geography (USD MN)
• Global Clinical Trials Market Analysis by Indication (USD MN)
• Global Clinical Trials Market Analysis in Autoimmune/Inflammation by Geography (USD MN)
• Global Clinical Trials Market Analysis in Pain Management by Geography (USD MN)
• Global Clinical Trials Market Analysis in Oncology by Geography (USD MN)
• Global Clinical Trials Market Analysis in CNS Condition by Geography (USD MN)
• Global Clinical Trials Market Analysis in Diabetes by Geography (USD MN)
• Global Clinical Trials Market Analysis in Obesity by Geography (USD MN)
• Global Clinical Trials Market Analysis in Cardiovascular by Geography (USD MN)
• Latin America Clinical Trials Market by Revenue
• Middle East & Africa Clinical Trials Market by Revenue
• Recent Development in Clinical Trials Industry
• Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.